LINKOPING, Sweden, August 31, 2022 /PRNewswire/ — Global medical imaging IT and cybersecurity company SECTRA (STO: SECT B) is launching a new business unit to drive innovation and product development in the genomics area. In the future, the Sectra Enterprise Diagnostics IT platform will be extended to efficiently handle genomic data—Sectra’s journey for an integrated diagnostic process. This multidisciplinary approach is especially important in cancer care.
“Genetic data is becoming increasingly important in diagnosis and precision medicine, especially in cancer treatment. Investing in genomics is aligned with our long-term ambition to be a leader in diagnostic data technology and can have a significant impact on patient care,” says Torbjörn. Kronander, president and CEO of Sectra.
The analysis of genetic information, genomics, is used today in health care to better understand and diagnose patients and to predict how an individual patient will respond to various treatments. Personalized care based on genetic information is often called precision medicine and is a rapidly growing field.
To take advantage of precision medicine opportunities and cope with the dramatic increase in patient data volumes, tomorrow’s IT solutions for diagnostics must support healthcare providers with data from various specialties for integrated diagnostic workflows, including genomics.
Sectra and University of Pennsylvania Health system, established PhiladelphiaCooperation has started to facilitate the development of effective IT solutions.
The new business unit is part of Sectra’s operational area of business innovation and will be led by it. Frederick Lysholm, Ph.D. in bioinformatics.
The IT solution for genomic data will be part of Sectra’s enterprise imaging solution, providing an integrated strategy for all imaging needs while reducing operational costs. A scalable and modular solution, with VNA, enables healthcare providers to scale from logic to logic and organization to organization. To read more about Sectra and find out why it ranks high in “Best in KLAS,” visit Sectra’s website.
About Sect
Sectra contributes to improving the efficiency of care in health systems around the world and helping authorities and defense forces to maintain a healthy and safe society. Europe To protect the society’s most sensitive information. In the year Founded in 1978, the company is based in Linköping, SwedenDirect sales in 19 countries and distribution partners worldwide. Total sales in the 2021/2022 fiscal year 1.949 million crores. Sectra shares are listed on the Nasdaq Stockholm exchange. Visit the Sectra website for more information.
For more information please contact:
Dr. Torbjörn Kronander, President and CEO Sectra AB, +46 (0) 705 23 52 27
This information comes from Cision http://news.cision.com.
https://news.cision.com/sectra/r/sectra-extends-medical-diagnostics-business-to-include-genomics-it,c3622957
The following files are available for download:
Source Sect
